SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000584
Filing Date
2021-04-09
Accepted
2021-04-09 17:21:30
Documents
1
Period of Report
2021-04-07

Document Format Files

Seq Description Document Type Size
1 singh_fm4april72021.html 4  
1 singh_fm4april72021.xml 4 3701
  Complete submission text file 0000905718-21-000584.txt   5162
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIODELIVERY SCIENCES INTERNATIONAL 4131 PARKLAKE AVE., SUITE 225 RALEIGH NC 27612
Business Address
Singh Vanila (Reporting) CIK: 0001795397 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40064 | Film No.: 21818605